CommercialCoverageMedium impact
Heart Failure Management Devices - (Effective Date - 2026-06-15) 7.01.91
Excellus BlueCross BlueShield·Cardiology, Cardiothoracic Surgery·Heart & Blood Vessels (Cardiovascular)
Effective date
Jun 15, 2026
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield has classified all heart failure management devices as investigational and non-covered, including CardioMEMS, V-LAP, Barostim, and cardiac contractility modulation devices. This means claims for these devices will be denied as experimental/investigational services.
Action Required
By June 15, 2026: Billing team must update system to flag heart failure management devices (CardioMEMS HF system, V-LAP, Barostim device, Optimizer Smart CCM devices) as non-covered investigational services for Excellus BlueCross BlueShield. Update encounter forms to alert providers that these devices are not covered. Claims will be denied if submitted.